Results 31 to 40 of about 718,788 (352)

Risk of critical illness among patients with solid cancers: a population-based observational study of 118,541 adults [PDF]

open access: yes, 2015
Importance: Critical illness may be a potential determinant of cancer outcomes and geographic variations, but its role has not been described before. Objective: To determine the incidence of admission to intensive care units (ICUs) within 2 years ...
Kinsella, John   +5 more
core   +1 more source

Lung Transplantation in Controlled Donation after Circulatory-Determination-of-Death Using Normothermic Abdominal Perfusion

open access: yesTransplant International
The main limitation to increased rates of lung transplantation (LT) continues to be the availability of suitable donors. At present, the largest source of lung allografts is still donation after the neurologic determination of death (brain-death donors ...
Paula Moreno   +7 more
doaj   +1 more source

Salvage resection of advanced mediastinal tumors [PDF]

open access: yes, 2019
The surgical treatment of locally advanced mediastinal tumors invading the great vessels and other nearby structures still represent a tricky question, principally due to the technical complexity of the resective phase, the contingent need to carry out
Andreetti, Claudio   +9 more
core   +1 more source

Some correlations between eight types of malignant neoplasms: A hint from cancer dynamics of 31 European countries in 20 years [PDF]

open access: yesNetwork Biology, 2017
In present study, the data of standardised death rates of malignant neoplasms per 100000 inhabitants in 31 European countries during 1994-2013 were used to analyze linear correlations between eight types of cancers in terms of induced death rates.
WenJun Zhang
doaj  

Incidentally Detected Malignancies in Lung Transplant Explants

open access: yesTransplantation Direct, 2019
Background. Active malignancy diagnosed within 5 years is an absolute contraindication for lung transplantation. In this study, we evaluated the rate of incidental malignancies detected in explanted lungs at our institution and assessed the ...
Dhruv A. Amratia, MD   +3 more
doaj   +1 more source

Neoplasms of the Lungs and Bronchi

open access: yesBritish Journal of Radiology: BIR Section, 1925
Malignant disease of the lungs is considered to be such a rarity, that it is usually given no more than a paragraph in our text books and is consequently seldom brought up in discussion of differential diagnosis. As long ago as 1889, Hare estimated that of all the deaths from pulmonary disease in London, 2·3 per cent, were due to primary neoplasms.
openaire   +1 more source

Expression of TIM-3 and Gal-9 Immune Checkpoints in Chronic Lymphocytic Leukemia: The Potential Role of Interleukin-27

open access: yesCurrent Issues in Molecular Biology
Background: Chronic lymphocytic leukemia (CLL) is characterized by malignant B lymphocyte accumulation and progressive immune dysfunction. The immune checkpoint molecule TIM-3 and its ligand galectin-9 (Gal-9) contribute to T cell exhaustion, impairing ...
Ewelina Wędrowska   +7 more
doaj   +1 more source

Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed

open access: yesCase Reports in Oncology, 2021
Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of nonsmall-cell lung cancer (NSCLC). It carries a poor prognosis, even among other subtypes of NSCLC.
Jan Alberto Paredes Mogica   +4 more
doaj   +1 more source

Risk for colorectal adenomas among patients with pancreatic intraductal papillary mucinous neoplasms: a prospective case-control study [PDF]

open access: yes, 2015
BACKGROUND AND AIMS: It has been reported that patients with intraductal papillary mucinous neoplasms of the pancreas are at an increased risk of colorectal cancer.
Panic, N   +11 more
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Home - About - Disclaimer - Privacy